TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| P | %ret | 1 | 1 | 2 | 2 | -3 | 1 | 25 | 30 | 61 | 19 |
| P | %wins | 100 | 50 | 50 | 100 | 100 | 100 | 83 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
3/12/09 18:50 | 3/11/09 | VRX | Valeant Pharmaceuticals International | DE | Health | Drug | Pharmaceutical Preparations | Blott Peter J | CA | O | EVP,CFO | P | 80 | 16.78 | 10 | 5 | 6 | 87 | 1 | 5 | -3 | 14 | 15 | 45 | |||||||||
11/14/08 19:10 | 11/14/08 | VRX | Valeant Pharmaceuticals International | DE | Health | Drug | Pharmaceutical Preparations | Blott Peter J | CA | O | EVP,CFO | P | 75 | 18.24 | 5 | 4 | 16 | 30 | D | -35 | -43 | -27 | -6 | -8 | 7 | -4 | 2 | 2 | -10 | 5 | 35 | 44 | 77 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |